← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Altman Peter
Chief Executive Officer | President
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001647542
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 21
- Purchases · 24M
- 43
- Average purchase
- $5.9K
- Median purchase
- $1.8K
- Gross purchase value
- $255.5K
Companies: BioCardia, Inc.
43 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-09-30 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $1.0K | Open filing |
| 2026-09-23 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $2.0K | Open filing |
| 2026-09-04 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $872 | Open filing |
| 2026-08-18 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $5.0K | Open filing |
| 2026-08-13 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $1.7K | Open filing |
| 2026-07-29 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $3.9K | Open filing |
| 2026-07-20 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $415 | Open filing |
| 2026-07-15 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $3.8K | Open filing |
| 2026-07-10 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $7.2K | Open filing |
| 2026-07-08 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $5.2K | Open filing |
| 2026-06-22 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $2.0K | Open filing |
| 2026-06-09 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $4.2K | Open filing |
| 2026-05-21 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $1.6K | Open filing |
| 2026-05-18 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $5.2K | Open filing |
| 2026-05-15 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $5.2K | Open filing |
| 2026-04-29 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $5.6K | Open filing |
| 2026-04-22 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $1.2K | Open filing |
| 2026-03-26 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $1.1K | Open filing |
| 2026-02-04 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $5.6K | Open filing |
| 2026-01-21 | BioCardia, Inc. | BCDA | Chief Executive Officer | President | $1.2K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 42Established | 97.7% (42/43) | 47.6% (20/42) | -0.5% | +1.5% | -16.7% |
| 20D | 41Established | 100.0% (41/41) | 56.1% (23/41) | +1.0% | +3.0% | -31.2% |
| 60D | 35Established | 94.6% (35/37) | 37.1% (13/35) | -11.6% | -8.5% | -38.7% |
| 120D | 26Established | 96.3% (26/27) | 3.8% (1/26) | -47.0% | -39.7% | -70.8% |
Research patterns
- First purchase in 12M
- 0/42
- Large purchase ≥ $100k
- 0/43
- Cluster buying · 15D
- 4/43
- Buying the dip
- 43/43
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.